Rajiv Malik - Viatris President
President
Mr. Rajiv Malik has served as President, Executive Director of Mylan N.V. since 2016. Mr. Malik has served as Mylans President since January 1, 2012 and has more than 35 years of experience in the pharmaceutical industry. Previously, Mr. Malik held various senior roles at Mylan, including Executive Vice President and Chief Operating Officer from July 2009 to December 2012, and Head of Global Technical Operations from January 2007 to July 2009. Mr. Malik was integral in developing the strategies for the companys acquisitions and, more importantly, in the execution and integration of acquisitions, specifically the generics business of Merck KgaA the injectables business of Bioniche Agila Specialties, a global injectables company the EPD Business Famy Care Ltd.s womens healthcare businesses Meda, a leading international specialty pharmaceutical company that sells prescription and overthecounter products and most recently, the nonsterile, topicalsfocused business of Renaissance Acquisition Holdings, LLC. Mr. Malik oversees the daytoday operations of the Company which includes commercial, scientific affairs, manufacturing, supply chain and quality as well as business development and information technology since 2016.
| Age | 57 |
| Tenure | 8 years |
| Phone | 44 1707 853 000 |
| Web | http://www.mylan.com |
Rajiv Malik Latest Insider Activity
Tracking and analyzing the buying and selling activities of Rajiv Malik against Viatris stock is an integral part of due diligence when investing in Viatris. Rajiv Malik insider activity provides valuable insight into whether Viatris is net buyers or sellers over its current business cycle. Note, Viatris insiders must abide by specific rules, including filing SEC forms every time they buy or sell Viatris'shares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Rajiv Malik over two weeks ago Acquisition by Rajiv Malik of 18845 shares of Viatris subject to Rule 16b-3 |
Viatris Management Efficiency
The company has Return on Asset of 3.63 % which means that on every $100 spent on assets, it made $3.63 of profit. This is considered to be average in the sector. In the same way, it shows a return on shareholders' equity (ROE) of 2.22 %, implying that it generated $2.22 on every 100 dollars invested. Viatris' management efficiency ratios could be used to measure how well Viatris manages its routine affairs as well as how well it operates its assets and liabilities.The company has 12.51 B in debt with debt to equity (D/E) ratio of 1.0, which is OK given its current industry classification. Viatris has a current ratio of 0.99, suggesting that it has not enough short term capital to pay financial commitments when the payables are due. Debt can assist Viatris until it has trouble settling it off, either with new capital or with free cash flow. So, Viatris' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Viatris sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Viatris to invest in growth at high rates of return. When we think about Viatris' use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | PRESIDENT Age | ||
| Lorrie Schultz | Q2 Holdings | 48 | |
| Detlef Krause | ServiceNow | N/A | |
| Dan Barahona | Qualys Inc | N/A | |
| David Schneider | ServiceNow | 51 | |
| Liana Gelikas | Sapiens International | N/A | |
| Kim Rutledge | Q2 Holdings | 51 | |
| Yoshihide Hata | NH Foods Ltd | 65 | |
| Takahito Ohkoso | NH Foods Ltd | N/A | |
| Hiroji Ohkoso | NH Foods Ltd | 62 | |
| Bruce Posey | Qualys Inc | 72 | |
| Barry Benton | Q2 Holdings | 61 | |
| Simon Azzopardi | Qualys Inc | N/A | |
| Juichi Suezawa | NH Foods Ltd | 62 | |
| Mark Hutnan | Qualys Inc | N/A | |
| Masatoshi Suzuki | ServiceNow | N/A | |
| Jonathan Price | Q2 Holdings | 40 | |
| Adam Blue | Q2 Holdings | 52 | |
| Scott Palmer | Sapiens International | N/A | |
| Cathy Mauzaize | ServiceNow | N/A | |
| Sherri Manning | Q2 Holdings | 48 | |
| Odus Wittenburg | Q2 Holdings | 46 | |
Management Performance
| Return On Equity | 2.22 | |||
| Return On Asset | 3.63 |
Viatris Leadership Team
Elected by the shareholders, the Viatris' board of directors comprises two types of representatives: Viatris inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Viatris. The board's role is to monitor Viatris' management team and ensure that shareholders' interests are well served. Viatris' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Viatris' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Anthony Mauro, President of Mylan North America | ||
| Joseph Maroon, Independent Director | ||
| Kris King, VP of Global Investor Relations | ||
| Heather Bresch, CEO, Executive Director and Member of Science and Technology Committee | ||
| Harry Korman, Non-Executive Independent Director | ||
| Melina Higgins, Independent Director | ||
| Mark Parrish, Independent Director | ||
| Kenneth Parks, CFO | ||
| Rodney Piatt, Vice Chairman of the Board, Lead Independent Director | ||
| Rajiv Malik, President, Executive Director and Member of Science and Technology Committee | ||
| John Sheehan, Executive Vice President CFO, Principal Financial officer | ||
| Dennis Zeleny, Chief Human Resource Officer | ||
| JoEllen Dillon, Independent Director | ||
| Neil Dimick, Independent Director | ||
| Sjoerd Vollebregt, Independent Director | ||
| Douglas Leech, Independent Director | ||
| Robert Cindrich, Independent Director | ||
| Pauline Mohr, Non-Executive Independent Director | ||
| Wendy Cameron, Independent Director | ||
| Rakesh Bamzai, President - India Commercial and Emerging Markets | ||
| Robert Coury, Executive Chairman and Chairman of Executive Committee | ||
| Daniel Gallagher, Chief Legal Officer | ||
| Richard Mark, Non-Executive Independent Director | ||
| Randall Vanderveen, Independent Director |
Viatris Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Viatris a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 2.22 | |||
| Return On Asset | 3.63 | |||
| Profit Margin | 2.31 % | |||
| Operating Margin | 30.50 % | |||
| Current Valuation | 20.35 B | |||
| Shares Outstanding | 541.55 M | |||
| Shares Owned By Insiders | 0.91 % | |||
| Shares Owned By Institutions | 90.50 % | |||
| Number Of Shares Shorted | 47.14 M | |||
| Price To Earning | 30.73 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Viatris in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Viatris' short interest history, or implied volatility extrapolated from Viatris options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in Viatris Stock
If you are still planning to invest in Viatris check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Viatris' history and understand the potential risks before investing.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |